Author
Dean E. Schraufnagel
Also Known As
Carrie Kujoth, D E Schraufnagel, D Schraufnagel, D. E. Schraufnagel, D. Schraufnagel, D.E. Schraufnagel, DE Schraufnagel, DEAN E. SCHRAUFNAGEL, Dean E Schraufnagel, Dean E. Schraufnagel
215
Publications
12.9K
Citations
50
H-Index
160
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 23 | 37 | 3.8K |
2 | Health Sciences | 12 | 12 | 812 |
3 | Public Health | 11 | 11 | 1.6K |
4 | Engineering | 2 | 2 | 50 |
5 | Natural Sciences | 1 | 1 | 23 |
Dean E. Schraufnagel
×
88
Publications
9.3K
Citations
42
H-Index
| Year | Citations | |
|---|---|---|
2006 | 1.6K | |
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial Donald P. Tashkin, Michael D. Roth, Philip J. Clements, The Lancet Respiratory Medicine Sls IiMycophenolate MofetilInflammatory Lung DiseaseAdvanced Lung DiseaseSystemic Scleroderma | 2016 | 1K |
2014 | 703 | |
2007 | 463 | |
2011 | 245 | |
2014 | 244 | |
2008 | 239 | |
2012 | 231 | |
2015 | 229 | |
2012 | 217 |
Page 1
Page 1